Works matching IS 17562856 AND DT 2024
Results: 196
Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241309431
- By:
- Publication type:
- Article
Intrinsic brain activity differences in drug-resistant epilepsy and well-controlled epilepsy patients: an EEG microstate analysis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241307846
- By:
- Publication type:
- Article
First line treatment with subcutaneous efgartigimod in impending myasthenic crisis: a case report.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241307687
- By:
- Publication type:
- Article
Complement inhibition in seropositive generalized myasthenia gravis as rescue therapy in impending and effective treatment in frequently recurring impending myasthenic crisis—a case series.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241301361
- By:
- Publication type:
- Article
Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241306684
- By:
- Publication type:
- Article
Early infarct growth rate is associated with symptomatic intracranial hemorrhage after endovascular thrombectomy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241306561
- By:
- Publication type:
- Article
Efficacy and safety of tocilizumab treatment in refractory MOG-IgG related optic neuritis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241306685
- By:
- Publication type:
- Article
Patient flow analysis with fast-track MRI for suspected stroke in the emergency department and associated non-comprehensive stroke center.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241303251
- By:
- Publication type:
- Article
A rare association of Guillain–Barré syndrome/Miller–Fisher syndrome overlap syndrome and Herpes Simplex Virus Type 1 infection: trigger or exacerbating factor?
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Clinical and radiological implications of subpotent generic fingolimod in multiple sclerosis: a case series.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241300047
- By:
- Publication type:
- Article
Short delay to initiate plasma exchange or immunoadsorption as synergistic therapies for patients in the acute phase of anti-NMDAR encephalitis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241276208
- By:
- Publication type:
- Article
Bacterial signature in retrieved thrombi of patients with acute ischemic stroke—a systematic review.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241296713
- By:
- Publication type:
- Article
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241278496
- By:
- Publication type:
- Article
SCALA: a randomized phase I trial comparing subcutaneous and intravenous alemtuzumab in patients with progressive multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241291655
- By:
- Publication type:
- Article
Identification of alemtuzumab-suitable multiple sclerosis patients in Slovakia and sequencing of post-alemtuzumab immunomodulatory treatment.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241285556
- By:
- Publication type:
- Article
Link between post-stroke psychopathology and scope-of-action awareness.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241282633
- By:
- Publication type:
- Article
Therapeutic effect of an inhaled levodopa dry powder formulation on off episodes in patients with Parkinson's disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241289207
- By:
- Publication type:
- Article
The impact of different lifestyle factors on disability in multiple sclerosis at older ages: a monocentric retrospective study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241284166
- By:
- Publication type:
- Article
Lower leukocytes pretreatment as a possible risk factor for therapy-induced leukopenia in interferon-beta-treated patients with multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241286497
- By:
- Publication type:
- Article
Possible clinical and radiological predictors of haemorrhagic transformation in acute stroke patients undergoing dual antiplatelet therapy: a clinical study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241289735
- By:
- Publication type:
- Article
Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241284372
- By:
- Publication type:
- Article
Personality traits in patients with multiple sclerosis: their association with nicotine dependence and polypharmacy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241279118
- By:
- Publication type:
- Article
Nerve decompression for diabetic peripheral neuropathy with nerve entrapment: a narrative review.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241265287
- By:
- Publication type:
- Article
Optimizing outcomes in drug-resistant mesial temporal lobe epilepsy patients undergoing stereoelectroencephalography-guided radiofrequency thermocoagulation.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241286867
- By:
- Publication type:
- Article
Thrombectomy for patients with a large infarct core: a study-level meta-analysis with trial sequential analysis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241285552
- By:
- Publication type:
- Article
Clinical and ethical challenges in decision-making for patients with disorders of consciousness and locked-in syndrome from Chinese neurologists' perspectives.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241283328
- By:
- Publication type:
- Article
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241277736
- By:
- Publication type:
- Article
Patient-reported treatment satisfaction in essential tremor: levels of satisfaction and predictors of satisfaction.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241271994
- By:
- Publication type:
- Article
Effects of visual feedback balance system combined with weight loss training system on balance and walking ability in the early rehabilitation stage of stroke: a randomized controlled exploratory study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241266512
- By:
- Publication type:
- Article
Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241281903
- By:
- Publication type:
- Article
Clinical and device-based predictors of improved experience of activities of daily living after a multidisciplinary inpatient treatment for people with Parkinson's disease: a cohort study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241277157
- By:
- Publication type:
- Article
Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241279125
- By:
- Publication type:
- Article
Targeting dorsal root ganglia for chemotherapy-induced peripheral neuropathy: from bench to bedside.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241252718
- By:
- Publication type:
- Article
CYP2C19 genotype and sodium channel blockers in lacosamide-treated children with epilepsy: two major determinants of trough lacosamide concentration or clinical response.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241273087
- By:
- Publication type:
- Article
Preliminary results on temporal evolution and clinical implications of atherosclerotic plaque in branch atheromatous disease after statin treatment.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241273902
- By:
- Publication type:
- Article
Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241276848
- By:
- Publication type:
- Article
Hemorrhagic complications after stroke treatment with intravenous thrombolysis despite use of direct oral anticoagulants: an observational study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241276206
- By:
- Publication type:
- Article
Efficacy and safety of patisiran for ATTRv-PN: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241273079
- By:
- Publication type:
- Article
The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241273045
- By:
- Publication type:
- Article
Pattern of pareses in 5q-spinal muscular atrophy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241263420
- By:
- Publication type:
- Article
The association of vagal atrophy with parameters of autonomic function in multiple system atrophy and progressive supranuclear palsy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241267300
- By:
- Publication type:
- Article
Management of delirium in acute stroke patients: a position paper by the Austrian Stroke Society on prevention, diagnosis, and treatment.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241258788
- By:
- Publication type:
- Article
No immediate change in systemic cytokines following an eccentric muscle training session in people with multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241266113
- By:
- Publication type:
- Article
The safety and efficacy profile of eculizumab in myasthenic crisis: a prospective small case series.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
A rare adverse effect in inebilizumab therapy for neuromyelitis optica spectrum disorder: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Therapeutic strategies during cenobamate treatment initiation: Delphi panel recommendations.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241256733
- By:
- Publication type:
- Article
Comparative effectiveness and safety of ozanimod versus other oral DMTs in relapsing-remitting multiple sclerosis: a synthesis of matching-adjusted indirect comparisons.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241237856
- By:
- Publication type:
- Article
Author response to Comment on: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Calcium channel blockers and Parkinson's disease: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241252713
- By:
- Publication type:
- Article
Comment on: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor